H1 2024 Life Sciences Update Market Summaries
Los Angeles & Orange County
View H1 2024 Life Sciences Update
View All Markets
Market Summary
Public & Private Funding (2024 1H)
Rent vs. Vacancy Comparison
Fast Lab Stats 8.6 MSF Market Square Footage $39.91 $ Per SF 2.8% Vacancy 42.0K Total Life Sciences Employment 14.8% Life Sciences Employment 10-Year Growth Rate Fast Lab Stats
• With approximately 8.6 msf of regional lab inventory, the Los Angeles and Orange County life sciences market has emerged as a growth market with great potential. Though smaller in scale compared to its national contemporaries, a surplus of aged and obsolete industrial flex and office space provides a hardy supply of renovation opportunities to meet the growing demand. • As of mid-year 2024, nearly 5,700 life sciences institutions called Los Angeles and Orange County home and employed over 42,000 people. The local economic output of the life sciences industry is estimated to be over $113.3 billion. • Many of the submarkets across Los Angeles and Orange County are viable locations for the life sciences industry due to their proximity to world-class institutions or because they are anchored in areas with significant workforce tailored toward the industry. These clusters include South Bay (El Segundo), LA North (Thousand Oaks), Tri-Cities (Pasadena), the Westside (Culver City, Santa Monica, et al.) and Orange County. By midyear 2024, most of the new leasing activity was concentrated in southern and coastal submarkets in Orange County, such as Irvine and Tustin. • As of July 2024, the Los Angeles and Orange County market was one of the largest beneficiaries of funding from the National Institutes of Health (NIH), totaling nearly $1.9 billion—or 32% of the NIH funding throughout the state of California. This was largely due to the region being home to several world class research and educational institutions, such as City of Hope, Caltech, USC, UCLA and Cal Poly Pomona.
0% 1% 2% 3% 4% 5% 6% 7% 8% 9%
$10 $15 $20 $25 $30 $35 $40 $45
Company
Deal Type
Completed VC Round $ Raised (MM)
CG Oncology (NAS: CGON)
IPO
Jan-2024
$380.0
TORL BioTherapeutics Later Stage VC
Apr-2024 3rd Round
$158.3
Vacancy Rate
ImmPACT Bio
Later Stage VC Later Stage VC Later Stage VC Early Stage VC Early Stage VC Later Stage VC Early Stage VC
Apr-2024 2nd Round $139.8 Feb-2024 3rd Round $135.0
Latigo Bio
Angitia Biopharmaceuticals
Jan-2024 4th Round
$86.0
Midi Health
Mar-2024 4th Round Jan-2024 3rd Round Apr-2024 1st Round May-2024 3rd Round
$60.0 $50.0 $33.0 $30.0
Average Asking Rent $/sf
$0 $5
Sonorous NV AccessHope
2015 2017 2019 2021
2023
Immunis
Asking Rents
Overall Vacancy
Sublease Vacancy
AtaCor Medical
Later Stage VC
Apr-2024 4th Round
$28.0
Representative Life Sciences Companies
Life Sciences Labor: Average Monthly Job Postings and Hires
Representative Lease Transactions (2024 1H)
Company
Address
Size (SF) New/Renewal
Type
Quarter Landlord
Company
Type R&D
2,500
Inari Medical
510 Technology Dr. 173 Technology Dr. 26630 Agoura Rd. 15771 Red Hill Ave.
27,197 New Lease 15,446 New Lease
Sublease
Q2
The Irvine Company The Irvine Company Arden Realty, Inc. Rexford Industrial
Kite Pharma
EnChannel Medical
Direct Direct
Q1
Top NIH-Funded Institutions (2020-2024 1H) $2.7B University of California Los Angeles $1.5B University of Southern California $879M University of California-Irvine Pharmaceutical Edwards Life Sciences Medical Devices Masimo Medical Devices Sanofi/Genzyme Pharmaceutical Celgene R&D Xencor R&D Baxter Pharmaceutical Seigfreid Pharmaceutical Grifols R&D Amgen
2,000
HRL Laboratories
15,080 Renewal
Q2
1,500
bioMérieux (Tempo CC)
13,775 New Lease 8,652 New Lease
Sublease
Q1 Q1
Velocity Clinical Research 1127 Wilshire Blvd.
Direct
Boulevard Investment Group
1,000
500
0
2020 2021
2022 2023 2024
Hires Unique Postings
Bio Degree-Awarding Institutions, Metro Area • California Institute of Technology • University of California – Los Angeles • University of Southern California • University of California – Irvine • California State Polytechnic U, Pomona
Annual Life Sciences Degree Completions
2013 8,535 2023 14,960 Up 75%
Research Contributors Dan Hunker Daniel.hunker@cushwake.com
Sources: Cushman & Wakefield Research, CoStar, National Institutes of Health (NIH), Lightcast, Pitchbook
CUSHMAN & WAKEFIELD
LIFE SCIENCES UPDATE | 2024 FEBRUARY
Made with FlippingBook - Online magazine maker